{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:40:20Z","timestamp":1760060420992,"version":"build-2065373602"},"reference-count":53,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Sentinel lymph node biopsy (SLNB) has transformed the management of cutaneous melanoma, emerging as a cornerstone in evaluating regional lymphatic spread while minimizing surgical morbidity. From its theoretical foundation laid by Cabanas to its refinement and clinical validation through landmark trials, SLNB has evolved into a standard of care with significant prognostic value. This review traces the historical trajectory of SLNB, analyzes current guidelines and controversies and explores future directions. Novel imaging technologies, such as indocyanine green fluorescence and augmented reality-assisted mapping, promise to enhance accuracy and reduce invasiveness. Furthermore, the advent of effective systemic therapies and neoadjuvant protocols is reshaping the therapeutic landscape, potentially redefining the role of SLNB in melanoma management. As precision medicine advances, SLNB remains an essential procedure, with its utility continually redefined by technological innovation and evolving oncologic strategies.<\/jats:p>","DOI":"10.3390\/medicina61091542","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T15:49:34Z","timestamp":1756309774000},"page":"1542","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Journey of Sentinel Lymph Node Biopsy in Cutaneous Melanoma: A Brief Narrative Review from Scalpel to Smart Tech"],"prefix":"10.3390","volume":"61","author":[{"given":"R\u01cezvan Ioan","family":"Andrei","sequence":"first","affiliation":[{"name":"Department of General Surgery, \u201cCarol Davila\u201d University of Medicine and Pharmacy, B-dul Eroii Sanitari 8, 050474 Bucharest, Romania"},{"name":"Department of Surgical Oncology, Institute of Oncology \u201cProf. Dr. Al. Trestioreanu\u201d, \u015eos. Fundeni 252, 022328 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silviu Cristian","family":"Voinea","sequence":"additional","affiliation":[{"name":"Department of General Surgery, \u201cCarol Davila\u201d University of Medicine and Pharmacy, B-dul Eroii Sanitari 8, 050474 Bucharest, Romania"},{"name":"Department of Surgical Oncology, Institute of Oncology \u201cProf. Dr. Al. Trestioreanu\u201d, \u015eos. Fundeni 252, 022328 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1325-2031","authenticated-orcid":false,"given":"Cristian Ioan","family":"Bordea","sequence":"additional","affiliation":[{"name":"Department of General Surgery, \u201cCarol Davila\u201d University of Medicine and Pharmacy, B-dul Eroii Sanitari 8, 050474 Bucharest, Romania"},{"name":"Department of Surgical Oncology, Institute of Oncology \u201cProf. Dr. Al. Trestioreanu\u201d, \u015eos. Fundeni 252, 022328 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aniela Roxana","family":"Nodi\u021bi","sequence":"additional","affiliation":[{"name":"Department of General Surgery, \u201cCarol Davila\u201d University of Medicine and Pharmacy, B-dul Eroii Sanitari 8, 050474 Bucharest, Romania"},{"name":"Department of Surgical Oncology, Institute of Oncology \u201cProf. Dr. Al. Trestioreanu\u201d, \u015eos. Fundeni 252, 022328 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teodora Mihaela","family":"Pelea\u0219\u0103","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Prof. Dr. \u201cAgrippa Ionescu\u201d Hospital, Str. Arhitect Ion Mincu 7, 011356 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandru","family":"Blidaru","sequence":"additional","affiliation":[{"name":"Department of General Surgery, \u201cCarol Davila\u201d University of Medicine and Pharmacy, B-dul Eroii Sanitari 8, 050474 Bucharest, Romania"},{"name":"Department of Surgical Oncology, Institute of Oncology \u201cProf. Dr. Al. Trestioreanu\u201d, \u015eos. Fundeni 252, 022328 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11864-018-0575-4","article-title":"Sentinel Lymph Node Biopsy and Completion Lymph Node Dissection for Melanoma","volume":"19","author":"Masoud","year":"2018","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/his.15011","article-title":"Sentinel lymph node assessment in melanoma: Current state and future directions","volume":"83","author":"Cheng","year":"2023","journal-title":"Histopathology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.ejso.2022.01.021","article-title":"Sentinel lymph node melanoma metastases: Assessment of tumor burden for clinical prediction of outcome in the first Multicenter Selective Lymphadenectomy Trial (MSLT-I)","volume":"48","author":"Cochran","year":"2022","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"W\u00f6lffer, M., Liechti, R., Constantinescu, M., Lese, I., and Zubler, C. (2024). Sentinel Lymph Node Detection in Cutaneous Melanoma Using Indocyanine Green-Based Near-Infrared Fluorescence Imaging: A Systematic Review and Meta-Analysis. Cancers, 16.","DOI":"10.3390\/cancers16142523"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.5603\/njo.104831","article-title":"The actual approach of sentinel node biopsy in cutaneous melanoma","volume":"75","author":"Szymaniak","year":"2025","journal-title":"Nowotw. J. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13550-017-0312-1","article-title":"Introducing navigation during melanoma-related sentinel lymph node procedures in the head-and-neck region","volume":"7","author":"KleinJan","year":"2017","journal-title":"EJNMMI Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1200\/EDBK_351153","article-title":"Current State of Adjuvant Therapy for Melanoma: Less Is More, or More Is Better?","volume":"42","author":"Lao","year":"2022","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1200\/JCO.23.00255","article-title":"Debating Sentinel Lymph Node Biopsy for Melanoma in the Modern Adjuvant Era","volume":"41","author":"Zhang","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_9","first-page":"1892","article-title":"Melanotic cancerous disease","volume":"2","author":"Snow","year":"1892","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/1097-0142(197702)39:2<456::AID-CNCR2820390214>3.0.CO;2-I","article-title":"An approach for the treatment of penile carcinoma","volume":"39","author":"Cabanas","year":"1977","journal-title":"Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1245\/ASO.2004.02.031","article-title":"Dr. Herbert Lumley Snow, MD, MRCS (1847\u20131930): The original champion of elective lymph node dissection in melanoma","volume":"11","author":"Neuhaus","year":"2004","journal-title":"Ann. Surg. Oncol. Off. J. Soc. Surg. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2217\/mmt-2016-0023","article-title":"Lymph node dissection for melanoma: Where do we stand?","volume":"4","author":"Neuwirth","year":"2017","journal-title":"Melanoma Manag."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/jso.25316","article-title":"Current management of regional lymph nodes in patients with melanoma","volume":"119","author":"Bartlett","year":"2019","journal-title":"J. Surg. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1245\/s10434-010-1203-0","article-title":"The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: Results of the Multicenter Selective Lymphadenectomy Trial (I)","volume":"17","author":"Faries","year":"2010","journal-title":"Ann. Surg. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/1097-0142(197803)41:3<948::AID-CNCR2820410324>3.0.CO;2-Z","article-title":"A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma.Preliminary results","volume":"41","author":"Sim","year":"1978","journal-title":"Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0025-6196(12)62768-2","article-title":"Lymphadenectomy in the Management of Stage I Malignant Melanoma: A Prospective Randomized Study","volume":"61","author":"Sim","year":"1986","journal-title":"Mayo Clin. Proc."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1002\/1097-0142(19820601)49:11<2420::AID-CNCR2820491133>3.0.CO;2-2","article-title":"Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities","volume":"49","author":"Veronesi","year":"1982","journal-title":"Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0140-6736(97)08260-3","article-title":"Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: A randomised trial","volume":"351","author":"Cascinelli","year":"1998","journal-title":"Lancet"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","article-title":"Technical details of intraoperative lymphatic mapping for early stage melanoma","volume":"127","author":"Morton","year":"1992","journal-title":"Arch. Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/00000658-197710000-00010","article-title":"A Rational Approach to the Surgical Management of Melanoma","volume":"186","author":"Holmes","year":"1977","journal-title":"Ann. Surg."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa060992","article-title":"Sentinel-node biopsy or nodal observation in melanoma","volume":"355","author":"Morton","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa1310460","article-title":"Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma","volume":"370","author":"Morton","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma","volume":"376","author":"Faries","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1470-2045(16)00141-8","article-title":"Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): A multicentre, randomised, phase 3 trial","volume":"17","author":"Leiter","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Roumen, R.M.H., Schuurman, M.S., Aarts, M.J., Maaskant-Braat, A.J.G., Vreugdenhil, G., Louwman, W.J., and Sapino, A. (2021). Survival of sentinel node biopsy versus observation in intermediate-thickness melanoma: A Dutch population-based study. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0252021"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1245\/s10434-017-6267-7","article-title":"Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update","volume":"25","author":"Wong","year":"2018","journal-title":"Ann. Surg. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1046\/j.1365-2168.2002.02236.x","article-title":"Tumour thickness as a predictor of occult lymph node metastases in patients with stage I and II melanoma undergoing sentinel lymph node biopsy","volume":"89","author":"Lens","year":"2002","journal-title":"Br. J. Surg."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/01.sla.0000086543.45557.cb","article-title":"Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: Therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases","volume":"238","author":"Morton","year":"2003","journal-title":"Ann. Surg."},{"key":"ref_29","unstructured":"(2024, September 25). Network, N.C.C. Melanoma: Cutaneous. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) 2024 23\/09\/2024; Version 3.2024. Available online: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cutaneous_melanoma.pdf."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1245\/s10434-014-4211-7","article-title":"Sentinel Lymph Node Biopsy in Thick-Melanoma Patients (N=350): What is Its Prognostic Role?","volume":"22","author":"Ribero","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Huang, H., Fu, Z., Ji, J., Huang, J., and Long, X. (2022). Predictive Values of Pathological and Clinical Risk Factors for Positivity of Sentinel Lymph Node Biopsy in Thin Melanoma: A Systematic Review and Meta-Analysis. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.817510"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jaad.2010.09.772","article-title":"Hazard rates for recurrent and secondary cutaneous melanoma: An analysis of 33,384 patients in the German Central Malignant Melanoma Registry","volume":"66","author":"Leiter","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1001\/jamadermatol.2023.3256","article-title":"Stage-Specific Risk of Recurrence and Death From Melanoma in Denmark, 2008-2021: A National Observational Cohort Study of 25,720 Patients With Stage IA to IV Melanoma","volume":"159","author":"Helvind","year":"2023","journal-title":"JAMA Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1245\/ASO.2005.05.016","article-title":"A nomogram that predicts the presence of sentinel node metastasis in melanoma with better discrimination than the American joint committee on cancer staging system","volume":"12","author":"Wong","year":"2005","journal-title":"Ann. Surg. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1200\/JCO.19.02362","article-title":"Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia Nomogram","volume":"38","author":"Lo","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1245\/s10434-007-9468-7","article-title":"Reliability of Lymphatic Mapping After Wide Local Excision of Cutaneous Melanoma","volume":"14","author":"Ariyan","year":"2007","journal-title":"Ann. Surg. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.annonc.2024.11.006","article-title":"Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"36","author":"Amaral","year":"2024","journal-title":"Ann. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ejso.2009.10.007","article-title":"Adverse reactions to patent blue V dye\u2014The NEW START and ALMANAC experience","volume":"36","author":"Barthelmes","year":"2010","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/DSS.0000000000000961","article-title":"Eight Years\u2019 Experience of Sentinel Lymph Node Biopsy in Melanoma Using Lymphoscintigraphy and Gamma Probe Detection After Radiocolloid Mapping","volume":"43","author":"Dang","year":"2017","journal-title":"Dermatol. Surg."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/08998280.2022.2147385","article-title":"Use of indocyanine green for sentinel lymph node biopsy in melanoma","volume":"36","author":"Kwizera","year":"2023","journal-title":"Bayl. Univ. Med. Cent. Proc."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"102167","DOI":"10.1016\/j.suronc.2024.102167","article-title":"ICG-guided sentinel lymph node biopsy in melanoma is as effective as blue dye: A retrospective analysis","volume":"57","author":"Lavy","year":"2024","journal-title":"Surg. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1038\/s41591-023-02583-2","article-title":"Adjuvant nivolumab in resected stage IIB\/C melanoma: Primary results from the randomized, phase 3 CheckMate 76K trial","volume":"29","author":"Kirkwood","year":"2023","journal-title":"Nat. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/S0140-6736(22)00562-1","article-title":"Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): A randomised, double-blind, phase 3 trial","volume":"399","author":"Luke","year":"2022","journal-title":"Lancet"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1056\/NEJMoa2211437","article-title":"Neoadjuvant\u2013Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma","volume":"388","author":"Patel","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41591-022-01851-x","article-title":"Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: The PRADO trial","volume":"28","author":"Reijers","year":"2022","journal-title":"Nat. Med."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Slominski, R.M., Sarna, T., P\u0142onka, P.M., Raman, C., Bro\u017cyna, A.A., and Slominski, A.T. (2022). Melanoma, Melanin, and Melanogenesis: The Yin and Yang Relationship. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.842496"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.humpath.2013.02.022","article-title":"Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma","volume":"44","author":"Carlson","year":"2013","journal-title":"Hum. Pathol."},{"key":"ref_48","first-page":"171","article-title":"Augmented reality for sentinel lymph node biopsy","volume":"19","author":"Seppi","year":"2024","journal-title":"Int. J. Comput. Assist. Radiol. Surg."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Brockmeyer, P., Wiechens, B., and Schliephake, H. (2023). The Role of Augmented Reality in the Advancement of Minimally Invasive Surgery Procedures: A Scoping Review. Bioengineering, 10.","DOI":"10.3390\/bioengineering10040501"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13000-023-01375-z","article-title":"Artificial intelligence in diagnostic pathology","volume":"18","author":"Shafi","year":"2023","journal-title":"Diagn. Pathol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/cac2.12012","article-title":"Emerging role of deep learning-based artificial intelligence in tumor pathology","volume":"40","author":"Jiang","year":"2020","journal-title":"Cancer Commun."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Ricciardi, E., Giordani, E., Ziccheddu, G., Falcone, I., Giacomini, P., Fanciulli, M., Russillo, M., Cerro, M., Ciliberto, G., and Morrone, A. (2023). Metastatic Melanoma: Liquid Biopsy as a New Precision Medicine Approach. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24044014"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13046-025-03322-w","article-title":"A scoping review of factors influencing the implementation of liquid biopsy for cancer care","volume":"44","author":"Sheriff","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/9\/1542\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:33:46Z","timestamp":1760034826000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/9\/1542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":53,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["medicina61091542"],"URL":"https:\/\/doi.org\/10.3390\/medicina61091542","relation":{},"ISSN":["1648-9144"],"issn-type":[{"type":"electronic","value":"1648-9144"}],"subject":[],"published":{"date-parts":[[2025,8,27]]}}}